Insys Therapeutics Inc. founder John Kapoor and five of his former underlings can put off reporting to prison until April after a federal judge granted a seventh postponement Monday, citing the ongoing COVID-19 pandemic and suggesting this delay will be the last.
Federal prosecutors on Friday opposed a bid by six Insys Therapeutics Inc. executives to delay prison for a seventh time amid the COVID-19 pandemic, saying the new Biden administration has promised to make prisons a priority in vaccine distribution.
A former Insys executive asked a federal judge Friday to delay her prison sentence to avoid "prison parenting" her teenage son in the middle of the pandemic, when she says he needs her most.
Insys Therapeutics Inc. founder John Kapoor on Friday again asked a federal judge to put off the start of his 66-month prison term for his role in a scheme to bribe doctors to prescribe the company's opioid, arguing he should receive a COVID-19 vaccine before going in.
Federal prosecutors urged the First Circuit on Monday to overturn a decision that vacated part of the landmark jury verdict in which five former Insys Therapeutics Inc. executives and managers were convicted of racketeering, arguing the evidence firmly supports the government's case.
A federal judge on Wednesday allowed six former Insys Therapeutics Inc. executives who were convicted of bribing doctors to prescribe opioids to delay reporting to prison until at least February due to the ongoing COVID-19 pandemic.
A former Insys executive who was convicted in a scheme to bribe doctors to prescribe opioids and who testified against his former colleagues asked a Massachusetts federal judge for another continuance of his prison sentence due to COVID-19, joining four of the executives he testified against who recently made similar requests.
Insys Therapeutics Inc. founder John Kapoor asked a Massachusetts federal judge Monday to delay his 5½-year prison sentence for bribing doctors to prescribe opioids, saying that with three previous coronavirus-related extensions already having been granted and the pandemic worse than ever, now is not the time to lock the 77-year-old up.
The U.S. Department of Justice's multibillion-dollar felony case blaming Purdue Pharma for "a national tragedy of addiction and deaths" involving narcotic painkillers is just one part of the DOJ's fast-growing criminal crackdown on the drug industry's opioid-crisis profiteering.
Arguing for a new trial Friday, Insys Therapeutics Inc. founder John Kapoor told the First Circuit that prosecutors unfairly made him "a scapegoat for the national opioid crisis" and sought to sway jurors with heartbreaking but irrelevant testimony by addicted patients.